» Subscribe Today!
More of what you want to know.
The Daily News

Forgot your password?
TDN Services
Research millions of people and properties [+]
Monitor any person, property or company [+]

Skip Navigation Links
Search results for 'Merck' | Search again
DeSoto Public Records:0
Shelby Public Records:53
West Tennessee:34
Middle Tennessee:25
East Tennessee:30

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

The Daily News subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again

Editorial Results (free)

1. Technology Rebound Sets Nasdaq on Course for Record High -

NEW YORK (AP) — Technology companies are soaring Thursday as investors remain optimistic about the sector even though much of the market has been shaken by fears about the trade war with China. The Nasdaq composite is on track for an all-time high. Industrial companies are also bouncing back as the market recovers most of its losses from a day ago. Software maker CA is jumping after chipmaker Broadcom agreed to buy it for $18.9 billion.

2. CDC Director Resigns Over Financial Conflicts of Interest -

NEW YORK (AP) – The director of the Centers for Disease Control and Prevention resigned Wednesday over financial conflicts of interest involving her investments in health care businesses.

3. SCS Looking To Move Out of Central Offices Near Fairgrounds -

Shelby County Schools is in the due diligence phase of a relocation out of its long-time central office near the Mid-South Fairgrounds. And it comes as the city is pursuing a redevelopment of the fairgrounds and areas around it.

4. Startup Wants to Bring Back Vioxx for Hemophilia Joint Pain -

TRENTON, N.J. (AP) – Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so.

Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke.

5. FDA Approves Better Vaccine Against Painful Shingles Virus -

U.S. regulators have approved a new, more effective vaccine to prevent painful shingles, which is caused by the chickenpox virus.

Drugmaker GlaxoSmithKline said the Food and Drug Administration approved it late Friday. It will be the second shingles vaccine in the U.S. market. Merck launched the first one in 2006.

6. Biz Leaders Quit Trump Panel After Charlottesville Comments -

WASHINGTON (AP) – A fourth business leader resigned Tuesday from President Donald Trump's White House jobs panel – the latest sign that corporate America's romance with Trump is faltering after his initial half-hearted response to violence by white supremacists in Charlottesville, Virginia.

7. Trump Names Hate Groups, Denouncing Charlottesville Violence -

WASHINGTON (AP) – Under relentless pressure, President Donald Trump on Monday named and condemned "repugnant" hate groups and declared that "racism is evil" in a far more forceful statement than he'd made earlier after deadly, race-fueled weekend clashes in Charlottesville, Virginia.

8. Ukraine Security Expert Fears for 'Whole World' -

NEW YORK (AP) — The Latest on a widespread cyberattack that is affecting companies and government systems (all times local):

3 p.m.

The head of a top Ukranian cybersecurity firm says it's too early to say if his country was singled out as the prime target but that its institutions, long a target of Russian hackers, may have been compromised through attrition.

9. UTHSC Hosting Pharmaceutical Safety Conference -

The University of Tennessee Health Science Center is working toward playing a major role in the safety and quality of medical products and the global pharmaceutical supply chain.

Its latest step in that direction is the university’s designation as a Center of Excellence in global medical product quality and pharmaceutical supply chain security. That comes from the Asia Pacific Economic Cooperation, an international forum supporting economic growth in the Asia-Pacific region.

10. FDA Approves 2nd Near-Copy of Remicade for Immune Disorders -

Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders.

The U.S. Food and Drug Administration approved Renflexis, developed by Samsung Bioepis Co. of South Korea. Its U.S. partner, Merck & Co. of Kenilworth, New Jersey, will market Renflexis.

11. Drugmakers Pledge Restraint, But Prices Will Still Soar -

TRENTON, N.J. (AP) – Several big drugmakers are trying to quell the ongoing furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases.

12. Legislator: Marijuana Law Has Problems -

State Rep. William Lamberth balks at the notion Memphis and Nashville are softening the punishment for simple pot possession.

13. Jury: Gilead Owes Merck $200M in Damages Over Drug Patents -

The federal jury in a patent trial has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing on patents for hepatitis C drugs.

The award is far below the damages Merck sought, but the trial moves to a new phase Wednesday. The jury, in San Jose, California, then will decide whether Merck & Co. is due royalties on sales of Gilead's hepatitis C drugs, Harvoni and Sovaldi.

14. Creating A Commercialization Culture -

How to Create a Culture Where You Can Capitalize on Innovation: A presentation by Jay Morgan, VP Global Innovation Bayer Consumer Care, given at the Back end of Innovation Conference, October 2015.

15. Convincing Girls, Women to Pursue Science and Math Careers -

Claudia Rawn is used to talking about science, so when asked to speak about women in the STEM disciplines, she was a bit out of her comfort zone.

The speaking invitation came from organizers with the University of Tennessee’s inaugural Women in STEM Research Symposium, held in April.

16. New Meds Help Drugmakers Weather Strong Dollar, Other Issues -

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges.

Pfizer Inc., Merck & Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their revenue from selling products overseas. Because they're purchased in local currencies, the strong dollar is depressing the sales' value.

17. Anixter Moving Memphis Distribution Operations -

A leading supplier of communications and security products, electrical and electronic wire and cable, fasteners and other small components is relocating to a new Memphis distribution center.

Anixter International Inc., which is based in the Chicago area, has leased 100,000 square feet at 4001 Hickory Hill Road inside Memphis Distribution Center. Anixter will be relocating from 4580 S. Mendenhall Road, where DDN is expanding.

18. US, German Drugmakers Team Up on Cancer Medicines -

TRENTON, N.J. (AP) – Pfizer said Monday that it will partner with German drug and chemical maker Merck in developing potential cancer drugs in a hot new medication class that harnesses the body's immune system to fight cancer.

19. Hot Yoga Plus Expands in Memphis -

Hot Yoga Plus, a Nashville-based yoga concept, is opening a second Memphis area location.

Hot Yoga Plus, founded by Memphian Susannah Herring, has signed a 2,015-square-foot lease at 9037 Poplar Ave. in Germantown. The new store is expected to open this fall and follows the original Memphis location in Laurelwood.

20. Hot Yoga Plus Expands in Memphis -

Hot Yoga Plus, a Nashville-based Yoga concept, is opening a second Memphis area location.

Hot Yoga Plus, founded by Memphian Susannah Herring, has signed a 2,015-square-foot lease at 9037 Poplar Ave. in Germantown. The new store is expected to open this fall and follows the original Memphis location in Laurelwood.

21. Merck to Pay $3.85 Billion for Hepatitis C Drug Developer -

TRENTON, N.J. (AP) – Merck & Co. will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies that quickly cure most patients with the blood-borne virus afflicting tens of millions.

22. Bayer to Buy Merck Consumer Business for $14.2 Billion -

TRENTON, N.J. (AP) – Germany's Bayer plans to buy U.S.-based Merck & Co.'s consumer health business, creating a combined medicine cabinet of household names from Bayer's aspirin to Merck's Claritin allergy pills.

23. Innovation for the Rest of Us -

Innovation, as a discipline, tends to be special assignment work that is reserved for the creative hotshots, iconoclasts, those in hot spots like Palo Alto, or on an esteemed university campus, such as MIT.

24. Panel Votes Down Heart Safety Claim for Naproxen -

SILVER SPRING, Md. (AP) – A majority of federal health experts said Tuesday that new research is not strong enough to conclude that naproxen, the pain reliever in Aleve and many other medications, is safer on the heart than rival drugs used by millions of Americans to treat arthritis and everyday aches and pains.

25. FDA Reconsiders Heart Safety of Common Pain Pills -

WASHINGTON (AP) – Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains.

26. Merck, Partners to Jointly Test Hot Cancer Drug -

Merck & Co.'s hot experimental cancer drug, already closely watched by investors, got more attention Wednesday after the company announced new alliances with three other drugmakers to test it in combination with their drugs.

27. New Drug Approvals From FDA Declined in 2013 -

WASHINGTON (AP) – The Food and Drug Administration approved 27 first-of-a-kind drugs in 2013, down from 39 new medications in 2012, which was a 15-year high.

Despite the decline, FDA officials say the tally of innovative medications approved last year is in line with the historical trend. On average, the FDA has approved 28 first-of-a-kind drugs annually over the past five years.

28. Healthy Memphis Common Table Marks 10 Years of Promoting Health -

With a motto of “eat healthy, eat less and move more,” Healthy Memphis Common Table (HMCT) has made its mark in the local community during the past decade, encouraging the public to lead healthier lifestyles and to “get activated” with their health and health care options.

29. Merck Third-Quarter Net Income Falls on Charges, Lower Sales -

Merck & Co.'s third-quarter profit plunged 35 percent because of competition from generic drugs, lower sales of its top-selling medicine, and restructuring and acquisition charges.

30. Obama Convening Export Panel at White House -

WASHINGTON (AP) – President Barack Obama says rising U.S. exports have been "one of the biggest bright spots" of the U.S. economy.

Obama in 2010 set a goal of doubling exports by 2015, but the country is not on track to meet that goal. However, Obama pointed out the United States now sells more goods overseas than ever before, and those sales have boosted the U.S. economy. Obama says "made in America" means something around the world.

31. Eureka Encourages Girls to Explore STEM Fields -

A small group of girls huddled around a car-like robot with long sensors as they worked on making sure the car will be able to complete a programmed route at an exhibition next week.

“Try this in front Dennisha,” said Ashley Jones, as she handed Dennisha Williams a small gray wheel.

32. FDA Has Safety Concerns With Merck Insomnia Drug -

WASHINGTON (AP) – Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

33. New Coupons Aim to Keep People Off Generic Drugs -

TRENTON, N.J. (AP) – If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know.

34. Drought Stress on Trees Deeper Than is Evident -

NASHVILLE, Tenn. (AP) — Tulip poplar trees are dropping yellowed leaves, white pines are shedding second-year needles months early and the depth of damage to Tennessee's trees from the current drought might not be immediately evident.

35. Dr. Scholl's Hoping to Massage Rickety Image -

NEW YORK (AP) – Dr. Scholl's wants to massage its arthritic image.

The 106-year-old company is airing TV ads beginning Monday to recast its orthopedic shoe inserts as "energizing cushions" that help people live life to the fullest.

36. Askew Nixon Ferguson Announces Promotions -

Askew Nixon Ferguson Architects has announced a trio of promotions in its Memphis office, 1500 Union Ave.

37. Boys Should Get HPV Vaccine Too, Panel Says -

ATLANTA (AP) — The controversial HPV shot given to girls should also be given to boys, in part to help prevent the spread of the virus through sex, a government medical panel said Tuesday.

38. Commission to Fill Carpenter’s Seat -

The Shelby County Commission should be back at full strength by the end of the Monday, Oct. 17, meeting of the body.

Monday’s agenda includes the appointment of a new District 1 commissioner to fill the vacancy created by the resignation of Mike Carpenter.

39. Six Apply for Carpenter’s Commission Seat -

Shelby County commissioners interview contenders Wednesday, Oct. 12, for the District 1 seat vacancy following the Oct. 1 resignation of Mike Carpenter, who left to become state director of StudentsFirst, an education reform nonprofit based in Nashville.

40. FDA Approves First Diabetes-Cholesterol Combo Pill -

TRENTON, N.J. (AP) – The first combination pill for the millions of people with the dangerous combination of diabetes and high cholesterol won U.S. approval Friday, offering convenience – and savings – to patients taking multiple pills.

41. Carpenter Reflects on Five-Year Run -

As Memphis voters prepare to bring to an end another city campaign season, Shelby County Commissioner Mike Carpenter just ended a five-year run on the Shelby County Commission.

42. More Than 1 in 10 Parents Skip, Delay Kids' Shots -

CHICAGO (AP) – By age 6, children should have vaccinations against 14 diseases, in at least two dozen separate doses, the U.S. government advises. More than 1 in 10 parents reject that, refusing some shots or delaying others mainly because of safety concerns, a national survey found.

43. Field Helps Businesses Guard Intellectual Property -

Attorney R. Mark Field is in the business of assisting clients with their information management needs. Many of these clients are corporations and business owners that use his expertise in guarding trade secrets – secrets that, if exposed, could remove any competitive advantage that may have been in place beforehand.

44. Merck Speeding Up Layoffs of Many US Employees -

WHITEHOUSE STATION, N.J. (AP) – Drugmaker Merck & Co. has told employees it can't reach its goal of cutting up to 13,000 jobs by 2015 just by eliminating vacant jobs, so it is speeding up layoffs in the U.S.

45. New Rules to Cut Confusion on Sunscreen Claims -

WASHINGTON (AP) – Help is on the way to consumers confused by the jumble of sun protection numbers and other claims on sunscreens.

Under new rules published Tuesday, sunscreens will have to prove they filter out both ultraviolet B rays and ultraviolet A rays to claim they protect against skin cancer.

46. MBGH Hands Out Health Honors -

The Memphis Business Group on Health Thursday awarded two insurance companies and five regional hospitals for their progress toward improving the quality of health care in the region during 2010.

Doctors and administrators from organizations such as Baptist Memorial Health Care Corp., Methodist Le Bonheur Health Care, St. Jude Children’s Research Hospital and the Regional Medical Center at Memphis, as well as representatives from companies such as FedEx Corp., First Horizon National Corp., Merck & Co. Inc. and Morgan Keegan & Co. Inc., attended the awards luncheon at the Holiday Inn University of Memphis, 3700 Central Ave.

47. GTx, Ipsen Terminate Drug Collaboration -

Memphis biopharmaceutical startup GTx Inc. said Wednesday it and French-based pharmaceutical giant Ipsen have mutually agreed to terminate their collaboration for the development and commercialization of toremifene.

48. GTx, Ipsen Terminate Drug Collaboration -

Memphis biopharmaceutical startup GTx Inc. said Wednesday it and French-based pharmaceutical giant Ipsen have mutually agreed to terminate their collaboration for the development and commercialization of toremifene.

49. GTx Reports Q4 Loss, but 2010 Profit -

Memphis-based biopharmaceutical company GTx Inc. Thursday reported a $7.5 million net loss in the fourth quarter, but posted a $15.3 million profit for the full-year, ended Dec. 31.

50. GTx Reports Q4 Loss, But 2010 Profit -

Memphis-based biopharmaceutical company GTx Inc. Thursday reported a $7.5 million net loss in the fourth quarter, but posted a $15.3 million profit for the full-year, ended Dec. 31.

51. GTx Reports Q4, Full-Year Financial Results -

GTx, Inc. (Nasdaq: GTXI) today provided a company update and reported financial results for the fourth quarter and full year 2010.

52. Accredo Revenue Reaches Record High, Parent Co. Medco Reports 11 Pct. Profit Increase -

NEW YORK (AP) — Medco Health Solutions Inc., the country's largest pharmacy benefits manager, said Tuesday its fourth-quarter profit rose 11 percent, reflecting an increase in mail-order prescriptions and its expanded service business.

53. Petty Joins Phoenix Power Group -

Doug Petty has joined Phoenix Power Group as the new vice president of sales and marketing.

Hometown: Memphis
I hold B.S. degrees in chemistry and industrial hygiene from the University of North Alabama
Work Experience:
I worked for 10 years as a specialty hospital sales representative for Merck Pharmaceuticals. For nine years I was a senior industrial hygienist for EnSafe Inc.
Activities you enjoy outside of work:
You can usually find me on a golf course, but I also spend time singing and playing guitar in the Memphis area. I enjoy watching Tigers football and basketball games and cooking out with friends.
Who has had the greatest influence on you?
My parents are my greatest influences. I obviously chose wisely.
What drew you to Phoenix Power Group?
I was drawn to the opportunity to become involved on the ground floor of such an innovative, revolutionary system. In addition, this was a chance to be associated with a talented and experienced group of professionals and investors. Based on my years of professional experience, I know a good thing when I see it.
What does your job as VP of sales and marketing entail?
Our company utilizes breakthrough technology to convert used oil into electricity in an environmentally responsible manner. My position utilizes my background in environmental science, regulation, and high-performance marketing and sales. My specific responsibilities include managing regulatory affairs, developing marketing materials, training and distributor support.
What do you consider your greatest professional accomplishments?
It would have to be the relationships that I’ve built with co-workers, clients and customers over the years. Those are things that can’t be measured on a spreadsheets or sales reports. Winning the Regional Medical Center’s 2007 Pharmaceutical Representative of the Year Award certainly comes to mind.
What do you most enjoy about your work?
The level of excitement and energy around the PPG organization is remarkable. I’ve been looking for the opportunity to help launch a potential “Next Big Thing” for quite a long time. It is hard not to be excited when your field of work is always pushing the edge and creating new challenges and opportunities. No one has done what we are doing, so we really are a “new” idea. That comes with challenges and benefits; but there is something unique about “creating” a product, something that a cubicle just can’t offer.

54. GTx Cuts Loss, Gets More Capital -

Memphis-based GTx Inc. completed its public offering of additional stock with help from another major investment by Joseph R. “Pitt” Hyde III.

55. GTx Cuts Loss, Gets More Capital -

Memphis-based GTx Inc. completed its public offering of additional stock with help from another major investment by Joseph R. “Pitt” Hyde III.

56. GTx, Needing Cash, Issues More Stock -

Memphis-based GTx Inc. will issue more stock in a bid to shore up its operating reserves.

The biopharmaceutical company needs more money to finance clinical trials and have working capital, according to a filing it made this week with the U.S. Securities and Exchange Commission.

57. Walgreen Names Berkowitz to Pharmacy Market Role -

DEERFIELD, Ill. (AP) – Drugstore operator Walgreen Co. said Thursday it has hired former Schering-Plough executive Jeffrey Berkowitz to take charge of its pharmacy contracting strategy.

58. Volunteers Sought for Diabetes Study -

Diabetes for Life needs more volunteers for a five-year demonstration project funded by a $2 million grant from The Merck Co. Foundation to reduce health disparities.

59. Memphis R&D Team Reinvents Dr. Scholl’s Brand -

The Memphis-based research and development team behind Dr. Scholl’s has scored another hit with the latest innovation for the more than 100-year-old brand of foot care products.

Kiosks that allow shoppers to step onto a sensor that measures their feet, identifies pressure points and recommends the proper insole are now up nationwide at major retailers. The 3,000-plus Dr. Scholl’s Custom Fit Orthotic Centers are on track to number 4,200 by October.

60. GTx’s Loss Widens on News of Abandoned Drug -

The write-off of investments related to the development of a drug that didn’t pan out caused GTx Inc. to have a bigger loss during the second quarter.

61. Merck’s Consumer Products Show Q2 Sales Increase -

Sales of consumer care products for Merck & Co. totaled $422 million during the second quarter of this year, an increase over the $381 million in sales from the same period a year ago.

62. Memphis Merck Site Spared From Closure -

Merck & Co Inc. announced Thursday that it will close eight manufacturing sites, but Memphis is not on the list.

The pharmaceutical giant is closing the manufacturing plants as well as eight research sites to streamline operations following its merger with Schering-Plough last November. With the merger, Merck acquired the Memphis-based consumer health products division of Schering-Plough Corp.

63. United Way Chooses Committee Chairman -

The United Way of the Mid-South has announced a new chairman for its volunteer board of directors.

William J. Logue, president and chief executive officer of FedEx Freight Corp., is the chairman of the board, while Martha Perine Beard of the Federal Reserve Bank of St. Louis Memphis Branch is chairman-elect.

64. Powerful Possibilities -

Oct. 29 turned into a day for window staring when the news came.

The top executives of GTx Inc. looked at the bleak gray of an overcast sky from the seventh floor of the Toyota Center, their minds gone blank.

65. Merck Q1 Sales Rise But Profits Fall on Charges -

Drugmaker Merck & Co. reported Tuesday double-digit sales growth for a half-dozen of its top medicines and favorable currency rates fueled a 7 percent jump in first-quarter sales, but large charges for its November deal to buy Schering-Plough Corp. pulled profit down sharply.

66. GTx Reports $44.3M Net Income -

GTx Inc. is pressing ahead with the development of a drug for muscle wasting in cancer patients after ending its partnership with Merck.

67. GTx CEO Addresses Ipsen Partnership -

The chief executive officer of GTx has learned a thing or two about partnerships as the Memphis-based biopharmaceutical company has struggled for profitability.

In the span of a week, GTx announced it was ending its two-and-a-half year partnership with Merck & Co. It then expanded its partnership with another pharmaceutical giant, Ipsen, of France.

68. GTx Affirms Partnership With Ipsen -

A week after ending its partnership with Merck & Co., Memphis-based GTx Inc. confirmed an expansion of its partnership with French pharmaceutical giant Ipsen.

69. GTx, Merck Part Ways -

Memphis-based GTx Inc. has ended its partnership with Merck & Co. to develop a drug to prevent wasting and muscle loss in cancer patients.

70. Pharma Giants Combine Animal Med Businesses -

Merck & Co. and France’s Snaofi-Aventis are uniting their animal health businesses to share 29 percent of the world’s $19 billion-a-year market for pet medicines.

71. Schering-Plough Purchase Hikes Merck Sales, Profit -

TRENTON, N.J. (AP) – Drugmaker Merck & Co. on Tuesday posted huge jumps in revenue and profit for the fourth quarter, mainly because of its purchase of Schering-Plough Corp., whose consumer products division is based in Memphis.

72. Baker Donelson’s Garrison Appointed Co-Chair Of ABA IP Subcommittee -

Grady M. Garrison, of counsel at Baker, Donelson, Bearman, Caldwell & Berkowitz PC, recently was appointed to serve as co-chair of the Intellectual Property Litigation Subcommittee for the American Bar Association Litigation Section.

73. FDA Drug Approvals Mostly Flat in 2009 -

WASHINGTON (AP) - New drugs cleared by the U.S. Food and Drug Administration last year kept pace with 2008, suggesting a much-touted push for drug safety has not slowed down approvals.

The FDA's new leaders did step up early warnings about potential drug safety issues and citations to companies that violate safety regulations.

74. Sanofi-Aventis to Buy Gold Bond Maker Chattem -

TRENTON, N.J. (AP) - French drugmaker Sanofi-Aventis SA said Monday it plans to buy the Chattanooga-based health-care company Chattem Inc., maker of over-the-counter mainstays like Gold Bond skin products, for $1.9 billion in cash.

75. Vaccines on Horizon for AIDS, Alzheimer's, Herpes -

MARIETTA, Pa. (AP) - Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.

76. GTx Releases Earnings Report, Touts Other Drugs -

What a difference a week makes.

Seven days after explaining why the U.S. Food and Drug Administration did not approve its first drug product, Memphis-based GTx Inc. hosted a second conference call Monday when it reported earnings for the third quarter.

77. Innova Courts Insurance Cos. For $20 Million -

Instead of taking it easy during the holidays, Innova officials will be calling on the corporate offices of insurance companies in a quest to raise $20 million by Jan. 1.

Insurance companies that invest with Innova Fund II LP – one of six venture funds selected Friday for a new state economic development initiative – will receive tax credits. The credits will allow insurance companies to offset a portion of their premium tax liabilities while they provide funding for fast-growth startup ventures.

78. More Evidence Surfaces in Shelter Crisis -

Disgusted with what in hindsight appears to have been widespread mistreatment of animals at the Memphis Animal Shelter, a shelter employee turned to an out-of-town specialist for help.

In September, the employee asked an expert from Florida who regularly is consulted in animal abuse cases to examine three dogs that had died at the shelter. That set in motion a chain of events leading to last week’s temporary closure of the facility, which was raided and battened down by sheriff’s deputies investigating the employee’s allegations of animal abuse and cruelty.

79. Merck, Now No. 2 Drugmaker, Set for Future Buys -

TRENTON, N.J. (AP) - The new Merck & Co. has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing.

80. GTx Receives ‘Complete Surprise’ From Food and Drug Admin -

The stock of Memphis-based GTx Inc. plunged 45 percent Monday morning after the company explained why the U.S. Food and Drug Administration did not grant approval for its drug to prevent bone fractures in men with prostate cancer who are undergoing hormone deprivation treatment.

81. Merck, Schering-Plough Receive FTC OK for Merger -

Merck & Co. Inc. and Schering-Plough Corp., which has its consumer products division based in Memphis, announced Friday they have received clearing from the U.S. Federal Trade Commission as well as foreign counterparts for the proposed merger of the global drug companies.

82. Shelter Crisis Tests Wharton’s Mettle Immediately -

Memphis Mayor A C Wharton Jr.’s first full day on the job began with a major crisis before the sun came up.

It started with a 5:15 a.m. raid of the Memphis Animal Shelter by Shelby County sheriff’s deputies. By the end of the day, the facility was closed to the public. And some shelter employees had been put on leave with pay while an investigation into alleged animal abuse and cruelty continued.

83. Criminal Charges Could Come In Shelter Investigation -

One or more people may face criminal charges once an investigation into alleged animal abuse and cruelty at the Memphis Animal Shelter wraps up, said Shelby County Dist. Atty. Gen. Bill Gibbons.

84. GlaxoSmithKline Changes Doctor Training Policy -

TRENTON, N.J. (AP) - British drugmaker GlaxoSmithKline PLC said Monday it is making major changes in its funding of educational programs for doctors, reducing the number it sponsors and switching its focus to independent ones with balanced information.

85. Sanofi Buys Merck's Half of Animal Health Business -

TRENTON, N.J. (AP) - French drugmaker Sanofi-Aventis SA has completed its $4 billion purchase of Merck & Co.'s half-interest in their veterinary medicine business, Merial Ltd., the companies said Friday.

86. Merck, British Charity to Jointly Develop Vaccines -

TRENTON, N.J. (AP) - Drugmaker Merck & Co. and Britain's largest charity, the Wellcome Trust, said Thursday they are starting a not-for-profit partnership to create affordable vaccines against diseases common in poor countries.

87. Current Account Deficit Dips to $98.8 Billion -

WASHINGTON (AP) - The deficit in the broadest measure of foreign trade shrank in the spring to the lowest level in relation to the total economy in 10 years, another dramatic sign of how much the recession had reduced America's appetite for foreign goods.

88. FDA Panel Backs Glaxo's Cervical Vaccine for Women -

WASHINGTON (AP) - Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women.

The U.S. Food and Drug Administration's vaccine panel voted overwhelmingly that the vaccine Cervarix appears safe and effective for girls and women ages 10 to 25.

89. FDA Says Glaxo Vaccine Blocks Cancer-Causing Virus -

WASHINGTON (AP) - A vaccine from GlaxoSmithKline successfully blocks the virus that causes most cases of cervical cancer, the Food and Drug Administration said Friday.

In documents posted online, the FDA said Cervarix – Glaxo's vaccine against human papilloma virus or HPV – successfully blocked the two most cancerous strains of the virus nearly 93 percent of the time.

90. Merck to Keep Schering’s Consumer Products Division -

The consumer health products division of Schering-Plough Corp., which is based in Memphis, will remain a core operation when the company is acquired by Merck & Co. Merck announced the new leadership and structure for the combined company on Monday. Richard T. Clark, the president and chief executive officer of Merck who will also head the combined company, said it “plans to place an increased emphasis on growing the consumer business, particularly in markets outside the United States.”

91. FDA Scrutinizes Infection Risk with Amgen Drug -

WASHINGTON (AP) - Federal health officials are questioning increased infection rates and tumors seen with an osteoporosis drug from Amgen that analysts say is key to the company's growth.

The U.S. Food and Drug Administration said Tuesday that patients taking Amgen Inc.'s denosumab were more likely to develop infections of the skin, ear and urinary tract than patients taking placebo.

92. Merck, Schering-Plough in $42M Vytorin Settlement -

TRENTON, N.J. (AP) - Merck & Co. and Schering-Plough Corp. said Wednesday they will pay $41.5 million to settle lawsuits claiming the drugmakers, partners on two blockbuster cholesterol drugs, delayed unfavorable study results because they would hurt sales.

93. Schering-Plough Seeks To Settle Merger Litigation -

Schering-Plough Corp, which has its consumer health products division based in Memphis, on Friday reported it had entered a proposed settlement in U.S. District Court in New Jersey to litigation seeking to block its merger with Merck & Co. Inc.

94. Drug Industry, Pfizer Lead in Health Lobbying -

WASHINGTON (AP) - The drug industry's trade group and one of the nation's biggest pharmaceutical companies reported spending more money than other health care organizations on lobbying in the second quarter of this year.

95. Merck, Portola in $470M Deal for Anticlotting Drug -

TRENTON, N.J. (AP) - Merck & Co. and Portola Pharmaceuticals Inc. said Thursday they have signed an exclusive deal to develop and market an experimental drug to prevent strokes in people with a dangerous irregular heart rhythm.

96. FDA: More Data Needed on Glaxo Nausea Drug -

TRENTON, N.J. (AP) - The U.S. Food and Drug Administration has rejected GlaxoSmithKline PLC's application to approve an experimental drug for nausea and vomiting, saying more data is needed.

97. FTC Requests More Info from Merck, Schering-Plough -

NEW YORK (AP) - Drugmakers Merck and Co. and Schering-Plough Corp., which are in the process of a $41.1 billion tie-up, said Monday the Federal Trade Commission has asked for more information about the deal.

98. Dodd's Wife Serves on Health Care Company Boards -

WASHINGTON (AP) - The wife of a senator playing a lead role on a national health care overhaul sits on the boards of four health care companies, one of several examples of lawmakers with ties to the medical industry.

99. Study: GTx Drug For Muscle Wasting Shows Promise -

A clinical trial of a GTx Inc. drug for muscle wasting in cancer patients shows benefits, according to a report the Memphis-based company released Thursday.

100. Merck's Heart Failure Drug Misses Trial Goals -

WHITEHOUSE STATION, N.J. (AP) - Merck and Co. said Friday its heart failure treatment rolofylline missed its goals in a trial, failing to improve patient symptoms compared with a placebo.